In females, although patients in the PMI-high group showed significantly better survival than those in the PMI-low group (P = 0.013, Figure 5 a), the difference in survival did not reach statistical significance (P = 0.213, Figure 5 b).
← all excerpts
Impact of Skeletal Muscle-related Parameters on Survival in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine plus Nab-paclitaxel as First-line Chemotherapy.
1
0.2130
0.2130